In a study published at the end of October in Nature Biotechnology and described in the Harvard Gazette, members of the Liu group demonstrate a new and more efficient method of delivering genome-editing proteins into target cells. The goal, to repair a few copies of a defective gene in certain disorders, is accomplished by introducing the non-replicable protein agents via common lipid reagents used routinely in DNA and RNA transfection.